It doesn't really matter if it can remain on the market if there is no coverage with payers = little to no revenue. It is basically similar to being pulled from market until potential FDA 2015 approval.
Yes sir, you nailed it on the head....
You Nailed It ! Your The Only One Here With A Brain !
Sentiment: Strong Sell
The Rest Are Brain-Dead !